287
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Animal Models of Sepsis

, &
Pages 195-212 | Published online: 09 Jul 2009

References

  • CDC. Increase in national hospital discharge survey rates for septicemia—United States, 1979–1987. Morb Mort Wkly Rep. 1990;39:31–34.
  • National Center for Health Statistics: Annual summary of births, marriages, divorces and deaths: United States 1988. Monthly Vital Stat Rep. 1989;37:1–10.
  • Schoenberg MH, Weiss M, Radermacher P. Out- come of patients with sepsis and septic shock af- ter ICU treatment. Langenbeck’s Arch Surg. 1998;383:44–48.
  • ACCP/SCCM consensus conference. Defnitions for sep- sis and organ failure and guidelines for the use of inno- vative therapies in sepsis. Chest. 1992;101:1644 –1655.
  • Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115:457 –469.
  • Bone RC. Why sepsis trials fail. JAMA. 1996;276:565 – 566.
  • Bone RC. Immunologic dissonance: A continuing evo- lution in our understanding of the Systemic Inflamma- tory Response Syndrome (SIRS) and the Multiple Or- gan Dysfunction Syndrome (MODS). Ann Intern Med. 1996;125:680 –687.
  • Do¨ cke WD, Syrbe U, Meinecke A, Platzer C, Makki A, Asadullah K, Klug C, Zuckermann H, Reinke P, Brunner H, von Baehr R, Volk HD. Improvement of monocyte function—a new therapeutic approach? In: Reinhart K, Eyrich K, Sprung C (eds.). Sepsis—Current perspectives in pathophysiology and therapy. Berlin Heidelberg New York: Springer-Verlag;1994:473–500.
  • Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock—relation to multiple-system organ failure and mortality. Chest. 1993;103:565 –575.
  • Neugebauer E, Rixen D, Raum M, Scha¨fer U. Thirty years of antimediator treatment in sepsis and septic shock—what have we learned? Langenbeck’s Arch Surg. 1998;383:26 –34.
  • Deitch EA. Animal models of sepsis and shock: A review and lessons learned. Shock. 1998;9:1–11.
  • Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing crit- ical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med. 1996;24:2059 – 2070.
  • Knaus WA, Wagner DP, Harrell FE, Draper EA. What de- termines prognosis in sepsis? Evidence for a compre- hensive individual patient risk assessment approach to the design and analysis of clinical trials. In: Reinhart K, Eyrich K, Sprung C (eds.). Sepsis—Current Perspectives in Pathophysiology and Therapy. Berlin Heidelberg New York: Springer-Verlag; 1994:23–37.
  • Fang XM, Schro¨ der S, Hoeft A, Stu¨ ber F. Comparison of two polymorphisms of the interleukin-1 gene fam- ily: interleukin-1 receptor antagonist polymorphism con- tributes to susceptibility to severe sepsis. Crit Care Med. 1999;27:1330 –1334.
  • Mira JP, Cariou A, Grall F, Declaux C, Losser MR, Heshmati glycopyranose glucan in vivo. Infect Immun. 1992; 60: 1642–1647.Arbibe L, Mignon A, Delpech M, Dhainaut JF. Associ- ation of TNF2, a TNF-® promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA. 1999;282:561–568.
  • Wakefeld CH, Carey PD, Foulds S, Monson JR, Gouillou PJ. Surgery and the release of a neutrophil Fc° receptor. Am J Surg. 1995;170:277–284.
  • Short BL, Gardiner WM, Walker RI, Fletcher JR, Rogers JE. Rat intraperitoneal sepsis—a clinically relevant model. Circ Shock. 1983;10:351 –359.
  • Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G. Anti-infective effect of poly-¯ 1-6-glucotriosyl-¯ 1-3-
  • DeMarsh PL, Wells GI, Lewandowski TF, Frey CL, Bhatnagar PK, Ostovic EJR. Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hemoregulatory peptide SK&F 107647. J Infect Dis. 1996;173:203 –211.
  • Wilkins TD, Walker CB, Nitzan D, Salyers AA. Experimen- tal infections with anaerobi c bacteria in mice. J Infect Dis. 1977;135:S13–S17.
  • Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflam- matory response syndrome (SIRS): A prospective study. JAMA. 1995;273:117 –123.
  • van Deventer SJH, Buller HR, ten Cate JW, Sturk A, Pauw W. Endotoxaemia: An early predictor of septicaemia in febrile patients. Lancet. 1988 Mar 19;1(8586):605 – 609.
  • Giroir BP. Mediators of septic shock: New approaches for interrupting the endogenou s inflammatory cascade. Crit Care Mede. 1993;21:780 –789.
  • Casey LC, Balk RA, Bone RC. Plasma cytokine and en- dotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771–778.
  • Hadjiminas DJ, McMasters KM, Peyton JC, Cheadl e WG. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J Surg Res. 1994;56:549 –555.
  • Fink MP, Heard SO. Laboratory models of sepsis and sep- tic shock. J Surg Res. 1990;49:186–196.
  • Suffredini AF, Parker MM, Brenner M, Schlesinger T, Parillo JE. Endotoxin (E) administration produces abnor- mal cardiovascular (CV) responses in normal humans. Clin Res. 1987;35:368A.
  • Revhaug A, Michie HR, Manson JMcK, Watters JM, Dinarello CA, Wolff SM, Wilmore DW. Inhibition of cyclo- oxygenase attenuates the metabolic response to endo- toxin in humans. Arch Surg. 1988;123:162–170.
  • Fish RE, Spitzer JA. Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: A unique model of chronic endotoxemia. Circ Shock. 1984;12:135 –149.
  • Fink MP, Morrissey PE, Stein KL, Clement RE, Fiallo V, Gardiner WM. Systemic and regional hemodynamic ef- fects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rab-F, Cheval C, Monchi M, Teboul JL, Riche´ F, Leleu G, bits. Circ Shock. 1988;26:41–57.
  • Bone HG, Waurick R, Van Aken H, Booke M, Prien T, Meyer J. Comparison of the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scav- enging in endotoxaemic sheep. Intensive Care Med. 1998;24:48–54.
  • Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiol. 1993;187:330 –345.
  • Kuppermann N, Nelson DS, Saladino RA, Thompson CM, Sattler F, Novitsky TJ, Fleisher GR, Siber GR. Compar- ison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats. J Infect Dis. 1994;170:630–635.
  • Galanos C, Freudenber g MA, Reutter W. Galactosamine- induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA. 1979;76:5939 –5934.
  • Shaw JHF, Wolfe RR. A conscious septic dog model with hemodynamic and metabolic responses similar to re- sponses of humans. Surgery. 1984;95:553 –561.
  • Cryer HM, Garrison RN, Kaebnick HW, Harris PD, Flint LM. Skeletal microcirculatory responses to hyperdynamic escherichia coli sepsis in unanesthetized rats. Arch Surg. 1987;122:86 –92.
  • Lorente JA, Landi´n L, Renes E, De Pablo R, Jorge P, Ro´ dena E, Liste D. Role of nitric oxide in the hemody- namic changes of sepsis. Crit Care Med. 1993;21:759 – 767.
  • Schlag G, Redl H, Davies J, Haller I. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994;2:10–18.
  • Kadletz M, Dignan RJ, Mullen PG, Windsor ACJ, Sugerman HJ, Wechsler AS. Pulmonary artery endothe- lial cell function in swine pseudomona s sepsis. J Surg Res. 1996;60:186 –192.
  • Lee PA, Weger GW, Pryor RW, Matson JR: Effects of flter pore size on effciacy of continuos arteriove- nous hemofltration therapy for Staphyloccus aureus- induced septicemia in immature swine. Crit Care Med. 1998;26:730 –737.
  • Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH. Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-° release while in- creasing IL-4/IL-10 production. J Surg Res. 1994;56:579 – 585.
  • Meyer TA, Wang J, Tiao GM, Ogle CK, Fischer JE, Hasselgren PO. Sepsis and endotoxemia stimulate in- testinal interleukin-6 production. Surgery. 1995;118:336–342.
  • Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, Isetta AM, Grau G, Buurman W, van Tits LJ, Ghezzi P. Pattern of cytokines and pharmacomodulatio n in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol. 1995;2:549–553.
  • Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G. Blockade of tumor necrosis factor re- duces lipopolysaccharide lethality, but not the lethal- ity of cecal ligation and puncture. Shock. 1995;4:89– 95.
  • Hotchkiss RS, Karl IE. Calcium: A regulator of the inflam- matory response in endotoxemia and sepsis. New Horiz. 1996;4:58–71.
  • Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun. 1993;61:2741 –2747.
  • Matejovic M, Rademache r P, Zulke C, Vlatten A, Altherr J, Brinkmann A, Bruckner UB, Jauch KW, Georgieff M, Trager K. Effects of the combined thromboxane receptor antagonist and synthase inhibitor DTTX-30 on intesti- nal O2-exchange and energy metabolism during hyper- dynamic porcine endotoxemia. Shock. 2000;13:307 – 313.
  • Dellinger P. Post-hoc analyses in sepsis trials: A formula for disappointment ? Crit Care Med. 1996;24:727 –729.
  • Lefering R, Neugebauer e E. Steroid controversy in sep- sis and septic shock: a meta-analysis. Crit Care Med. 1995;23:1294 –1303.
  • Cohen J: Meningococcal disease as a model to eval- uate novel anti-sepsis strategies. Crit Care Med. 2000 Sep;28(9):S64–67
  • Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock—A review of laboratory models and a proposal. J Surg Res. 1980;29:189 –201.
  • Mink SN, Li X, Bose D, Gu M, Liu G, Jacobs H, Light RB. Early but not delayed continuous arteriovenous hemofl- tration improves cardiovascular function in sepsis in dogs. Intens Care Med. 1999;25:733 –743.
  • Andersson R, Pettersson M, Ahre´ n B. Glucose tolerance and insulin secretion in experimental peritonitis in the rat. Eur Surg Res. 1990;22:101 –112.
  • Kresta A, Shek PN, Odumeru J, Bohnen JMA. Distribution of free and liposome-encapsulated Cefoxitin in experi- mental intra-abdominal sepsis in rats. J Pharm Pharma- col. 1993;45:779 –783.
  • Almdahl SM, BØgwald J, Hoffmann J, Seljelid R. Treat- ment of experimental peritonitis in rats by transfer of peritoneal mononuclear cells from rats injected with semisoluble aminated glucan. Acta Chir Scand. 1987; 153:535–539.
  • Ahrenholz DH, Simmons RL. Fibrin in peritonitis. I. Bene- fcial and adverse effects of fbrin in experimental E. coli peritonitis. Surgery. 1980;88:41–46.
  • Martinell S, Falk A, Haglund U, Myrvold H. Peritonitis and septic shock—An evaluation of two experimental models in the rat. Eur Surg Res. 1985;17:160 –166.
  • Alexander JW, Gonce SJ, Miskell PW, Peck MD, Sax H. A new model for studying nutrition in peritonitis. Ann Surg. 1989;209:334–340.
  • Hansson L, Alwmark A, Christensen P, Jeppsson B, Holst E, Bengmark S. Standardized intraabdominal abscess for- mation with generalized sepsis: Pathophysiology in the rat. Eur Surg Res. 1985;17:155 –159.
  • Hansson L, Folkesson HG, Andersson R, Jeppsson B, Holst E, Westro¨ m BR, Ahre´ n B. Increased passage of bovine serum albumin over the respiratory tract after intratracheal instillation during septic shock in rats. Eur Surg Res. 1992;24:45–53.
  • Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritoni- tis: Comparison with two nonselective strategies. Shock. 1996;5:116–121.
  • Steinwald PM, Whang KT, Becker KL, Snider RH, Nylen ES, White JC. Elevated calcitonin precursor levels are re- lated to mortality in an animal model of sepsis. Crit Care. 1999;3:11–16.
  • Vary TC, Kimball SR. Regulation of hepatic protein syn- thesis in chronic inflammation and sepsis. Am J Physiol. 1992;262:C445–C452.
  • Natanson C, Danner RL, Fink MP, MacVittie TJ, Walker RI, Conklin JJ, JE Parillo. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol. 1988;254:H558–H569.
  • Goldfarb RD, Glock D, Kumar A, McCarthy RJ, Mei J, Guynn T, Matushek M, Trenholme G, Parrillo JE. A porcine model of peritonitis and bacteremia simulates human septic shock. Shock. 1996;6:442–451.
  • Dubrow T, Schwartz RJ, McKissock J, Wilson SE. Effect of aerosolized fbrin solution on intraperitoneal contam- ination. Arch Surg. 1991;126:80–83.
  • Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL. Antimicrobial therapy of experimental in- traabdominal sepsis. J Infect Dis. 1975;132:282 –286.
  • Gurtner GC, Robertson CS, Chung SCS, Ling TKW, Ip SM, Li AKC. Effect of carbon dioxide pneumoperitoneu m on bacteraemia and endotoxaemia in an animal model of peritonitis. Brit J Surg. 1995;82:844 –848.
  • Bersten AD, Rutten AJ. Renovascular interaction of epinephrine, dopamine and intraperitoneal sepsis. Crit Care Med. 1995;23:537–544.
  • Berger D, Buttenschoen K. Managemen t of abdominal sepsis. Langenbeck’s Arch Surg. 1998;383:35 –43.
  • Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg. 1996;224:10 –18.
  • Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL. Lessons from an animal model of intra-abdominal sepsis. Arch Surg. 1978;113:853–857.
  • Kazarian KK, Perdue PW, Lynch W, Dziki A, Nevola J, Lee CH, Hayward I, Williams T, Law WR. Porcine peri- toneal sepsis: Modeling for clinical relevance. Shock. 1994;1:201–212.
  • Arvidsson D, Almquist P, Haglund U. Effects of Posi- tive end-expiratory pressure on splanchnic circulation and function in experimental peritonitis. Arch Surg. 1991;126:631 –636.
  • Gomez J, Ros J, Ruiz J, Canteras M, Valde´ s M, Marti´n- Luengo F. Comparison of the effcacy of three differ- ent treatments with imipenem versus the classical clin- damycin plus tobramycin in experimental peritonitis. J Chemother. 1991;3:367–371.
  • Donnenberg MS: Pathogeni c strategies of enteric bacteria. Nature 17 Aug 2000;406:768 –774.
  • Chaudry IH, Wichtermann KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery. 1979;85:205 –211.
  • Read TE, Grunfeld C, Kumwenda ZL, Calhoun MC, Kane JP, Feingold KR, Rapp JH. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med. 1995;182:267 – 272.
  • Ahrendt GM, Tantry US, Barbul A. Intra-abdominal sepsis impairs colonic reparative collagen synthesis. Am J Surg. 1996;171:102 –108.
  • Martin CM, Sibbald WJ. Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rat. Am J Respir Crit Care Med. 1994;150:1539 –1544.
  • Yaghi A, Paterson NAM, McCormack DG. Vascular re- activity in sepsis: Importance of controls and role of nitric oxide. Am J Resp Crit Care Med. 1995;151:706 – 712.
  • Mizobata Y, Prechek D, Rounds JD, Robinson V, Wilmore DW, Jacobs DO. The duration of infection modifes mito- chondrial oxidative capacity in rat skeletal muscle. J Surg Res. 1995;59:165 –173.
  • Tang C, Liu MS. Initial externalization followed by inter- nalization of ¯ -adrenergic receptors in rat heart during sepsis. Am J Physiol. 1996;270:R254–R263.
  • Chen SJ, Wu CC, Yen MH. Alterations of ex vivo vascular reactivity in intraperitoneal sepsis. J Cardiovasc Pharma- col. 1994;24:786–793.
  • Hwang TL, Lau YT, Chen MF, Tang C, Liu MS. Biphasic intracellular redistribution of ®1-adrenergic receptors in rat liver during sepsis. Am J Physiol. 1993;265:R385– R391.
  • Fox GA, Paterson NAM, McCormack DG. Cyclooxy genase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. J Cardiovasc Pharmacol. 1996; 28:30–35.
  • Fox GA, Paterson NAM, McCormack DG. Effect of inhibi- tion of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. Am J Physiol. 1994;267:H1377– H1382.
  • Wang P, Ba ZF, Chaudry IH. Endothelium-dependen t re- laxation is depressed at the macro-and microcirculatory levels during sepsis. Am J Physiol. 1995;269:R988–R994.
  • Wang P, Ba ZF, Chaudry IH. Nitric oxide—To block or to enhance its production during sepsis? Arch Surg. 1994;129:1137 –1143.
  • Linz DN, Garcia VF, Arya G, Hug G, Tombragel E, Landrigan E, Chuck G, Tsoras M, Ryan M, Ziegler MM. Weanling and adult rats differ in fatty acid and carni- tine metabolism during sepsis. J Ped Surg. 1995;30:959 – 966.
  • Okamoto I, Abe M, Shibata K, Shimizu N Sakata N, Katsuragi T, Tanaka K. Evaluating the role of inducible ni- tric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury pro- duced by cecal ligation and puncture. Am J Respir Crit Care Med. 2000;162:716 –722.
  • Barke RA, Birklid S, Chapin RB, Roy S, Brady PS, Brady LJ. The effect of surgical treatment following peritoneal sep- sis on hepatic gene expression. J Surg Res. 1996;60:101–106.
  • Whang EE, Dunn JC, Mahanty H, McFadden DW, Zinner MJ, Ashley SW. Endotoxin inhibitor prevents sepsis- induced alterations in intestinal ion transport. Am J Surg. 1996;172:341 –344.
  • Refsum SE, Halliday MI, Campbel l G, McCaigue M, Rowlands BJ, Boston VE. Modulation of TNF® and IL-6 in a peritonitis model using Pentoxifylline. J Ped Surg. 1996;31:928 –930.
  • Kadoi Y, Saito S, Kunimoto F, Imai T, Fujita T. Impairment of the brain ¯ -adrenergic system during experimental endotoxemia. J Surg Res. 1996;61:496 –502.
  • Roy S, Charbonea u R, Cain KJ, Chapin RB, Barke RA. The possible role of a central nervous system dopamin- ergic mechanism in hepatic c-fos protein expression following peritoneal sepsis. Arch Surg. 1995;130:1209 – 1216.
  • Schro¨ppel B, Moch D, Marinzig M, Bru¨ckner UB: Effects of hydroxyethyl starch-deferoxamine on arachidonic acid metabolism and small bowel perfusion in early sepsis. J Invest Surg. 1997;10:173 –182.
  • Villar J, Ribeiro SP, Mullen JBM, Kuliszewski M, Post M, Slutsky AS. Induction of the heat shock response reduces mortalitiy rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med. 1994;22:914 – 921.
  • Baker CC, Chaudry IH, Gaines HO, Baue AE. Evalua- tion of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94:331 –335.
  • Hadjiminas DJ, McMasters KM, Robertson SE, Cheadl e WG. Enhanced survival from cecal ligation and punc- tur with pentoxify lline is associated with altered neu- trophil traffcking and reduced interleukin-1¯ expression but not inhibition of tumor necrosis factor synthesis. Surgery. 1994;116:348 –355.
  • Wichmann MW, Haisken JM, Ayala A, Chaudry IH. Melatonin administration following hemorrhagi c shock decreases mortality from subsequent septic challenge. J Surg Res. 1996;65:109 –114.
  • Benjamin CF, Ferreira SH, Cunha FdQ: Role of nitric oxide in the failure of neutrophil migration in sepsis. J Inf Dis. 2000;182:214 –223.
  • Kodama S, Mikawa K, Nishina K, Maekawa N, Kagawa T, Obara H. Lidocaine attenuates sepsis-induced di- aphragmatic dysfunction in hamsters. Crit Care Med. 2000;28:2475 –2479.
  • Burchard KW, Simms HH, Robinson A, DiAmico R, Gann DS. Hypocalcemia during sepsis—Relationship to resus- citation and hemodynamics. Arch Surg. 1992;127:265 – 272.
  • Hirschl RB, Heiss KF, Cilley RE, Hultquist KA, Housner J, Bartlett RH. Oxygen kinetics in experimental sepsis. Surgery. 1992;112:37 –44.
  • Walker JF, Cumming AD, Lindsay RM, Solez K, Linton AL. The renal response produced by nonhypotensive sepsis in a large animal model. Am J Kidney Dis. 1986;8:88–97.
  • Bloos F, Martin CM, Ellis CG, Sibbald WJ: Effects of mod- est anemia on systemic and coronary circulation of septic sheep. Am J Physiol 1999;277:H2195–H2204.
  • Raper RF, Sibbald WJ, Hobson J, Neal A, Cheung H. Changes in myocardial blood flow rates during hyper- dynamic sepsis with induced changes in arterial per- fusing pressures and metabolic need. Crit Care Med. 1993;21:1192 –1199.
  • Fox GA, Lam CJ, Darragh WB, Neal AM, Inman KJ, Rutledge FS, Sibbald WJ. Circulatory sequelae of admin- istering CPAP in hyperdynamic sepsis are time depen- dent. J Appl Physiol. 1996;81:976 –984.
  • Gnidec AG, Finley RR, Sibbald WJ. Effect of dobutamine on lung microvascular fluid flux in sheep with “sepsis syndrome”. Chest. 1988;93:181 –186.
  • Avila A, Warshawski F, Sibbald WJ, Finley RR, Wells G, Holliday R. Peripheral lymph flow in sheep with bacterial peritonitis: Evidence for increased peripheral microvascular permeability accompanying systemic sepsis. Surgery. 1985;97:685 –695.
  • Bloos FM, Morisaki HM, Neal AM, Martin CM, Ellis CG, Sibbald WJ. Sepsis depresses the metabolic oxygen re- serve of the coronary circulation in mature sheep. Am J Respir Crit Care Med. 1996;153:1577 –1584.
  • Fox GA, Berstein A, Lam C, Neal A, Rutledge FS, Inman K, Sibbald WJ. Hematocrit modifes the circulatory control of systemic and myocardial oxygen utilization in septic sheep. Crit Care Med. 1994;22:470 –479.
  • Cumming AD, Nimmo GR. Hemodynamic, renal and hor- monal actions of aprotinin in an ovine model of septic shock. Crit Care Med. 1992;20:1134 –1139.
  • Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun. 1998;66:2300–2309.
  • Bauer P, Lush CW, Kvietys PR, Russel JM, Granger DN. Role of endotoxin in the expression of endothelial se- lectins after cecal ligation and perforation. Am J Physiol. 2000;278:R1140–R1147.
  • Ayala A, Song GY, Chung CS, Redmond KM, Chaudry ICH. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med. 2000;28:2949 –2955.
  • McMasters KM, Peyton JC, Hadjiminas DJ, Cheadl e WG. Endotoxin and tumor necrosis factor do not cause mortality from cecal ligation and puncture. Cytokine. 1994;6:530–536.
  • Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/shock-associated multiple organ failure. Inlamm Res 1998;47:201 –210.
  • Coimbra R, Hoyt DB, Junger WG, Angle N, Wolf P, Loomis W, Evers MF. Hypertonic saline resuscitation de- creases susceptibility to sepsis after hemorrhagi c shock. J Trauma. 1997;42:602 –606.
  • Kelly JL, O’Sullivan C, O’Riordain M, O’Riordain D, Lyons A, Doherty J, Mannick JA, Rodrick ML. Is circu- lating endotoxin the trigger for the Systemic Inflamma- tory Response Syndrome seen after injury? Ann Surg. 1997;225:530 –543.
  • Gennari R, Alexander JW, Gianotti L, Eaves-Pyles T, Hartmann S. Granulocyte macrophage colony- stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance. Ann Surg. 1994; 220:68–76.
  • Garrison JL, Cunningha m PR, Lust RM, Thomas FT. Donor-specifc tolerance permits burn allografting with- out increased sepsis. J Surg Res. 1990;49:390–393.
  • Napolitano LM, Campbel l C. Polymicrobial sepsis follow- ing trauma inhibits interleukin-10 secretion and lympho- cyte proliferation. J Trauma. 1995;39:104–111.
  • Dwenger D, Remmers D, Grotz M, Pape HC, Regel G, Tscherne H. Oxygen radical scavenging by ascorbic acid and inhibition of proteinases by aprotinin prevented the neutrophil-associated organ failure—a therapeutic approach. Langenbeck’s Arch Surg. 1995; Chirurgisches Forum 1995:623–626.
  • Andersson R, Foss A. Abdominal sepsis following liver re- section in the rat. Hepato-Gastroenterol. 1991;38:547 – 549.
  • Wang P, Ba ZF, Reich SS, Zhou M, Holme KR, Chaudry IH. Effects of nonanticoagulan t heparin on cardiovascu- lar and hepatocellular function after hemorrhagic shock. Am J Physiol. 1996;270:H1294–H1302.
  • Ding JW, Andersson R, Norgren L, Stenram U, Bengmar k S. The influence of biliary obstruction and sepsis on reticuloendothelial function in rats. Eur J Surg. 1992;158:157 –164.
  • Wang Q, Pantzar N, Jeppsson B, Westro¨ m BR, Karlsson BW. Increased intestinal marker absorption due to re- gional permeability changes and decreased intestinal transit during sepsis in the rat. Scand J Gastroenterol. 1994;29:1001 –1008.
  • Maessen JG, Greve JWM, Buurman WA. Increased sensi- tivity to endotoxemia by tissue necrosis. Surgery. 1991; 109:154–159.
  • Hyde SR, McCallum RE. Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun. 1992;60:976 –982.
  • Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med. 1997;25:106 –110.
  • O’Keefe GE, Hunt JL, Purdue GF. An evaluation of risk factors for mortality after burn trauma and the identifcation of gender-dependen t differences in outcomes. J Am Coll Surg 2001;192:153 –160.
  • Fink MP, Kaups KL, Wang H, Rothschild HR. Mainte- nance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery. 1991;110:154 –161.
  • Wilson MA, Chou MC, Spain DA, Downard PJ, Qian Q, Cheadle WG, Garrison RN. Fluid resuscitation attenu- ates early cytokine mRNA expression after peritonitis. J Trauma. 1996;41:622 –627.
  • Piper RD, Pitt-Hyde M, Li F, Sibbald WJ, Potter RF. Micro- circulatory changes in rat skeletal muscle in sepsis. Am J Respir Crit Care Med. 1996;154:931–937.
  • Farquhar I, Martin CMM, Lam C, Potter R, Ellis CG, Sibbald WJ. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res. 1996;61:190 –196.
  • Hersch M: Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ. Histologic and ultrastructural changes in nonpulmonar y organs during early hyperdynamic sepsis. Surgery. 1990;107:397 –410.
  • Richmond JM, Walker JF, Avila A, Petrakis A, Finley RJ, Sibbald WJ, Linton AL. Renal and cardiovascu- lar response to nonhypotensive sepsis in a large animal model with peritonitis. Surgery. 1985;97:205 – 213.
  • Cameron EM, Zhuang J, Nenconi MJ, Phipps R, Fink MP. Dantrolene, an inhibitor of intracellular calcium re- lease, fails to increase survival in a rat model of in- traabdominal sepsis. Crit Care Med. 1996;24:1537 – 1542.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.